XTX Markets’s Amgen AMGN Stock Holding History

XTX Markets’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,907	Closed	-$387K	–	144
2020 Q1	$387K	Buy	+1,907	New	+$417K	1.27%	26

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XTX Markets's AMGN Position: Q2 2020 in Review

XTX Markets sold out of Amgen (AMGN) in Q2 2020, closing a stake of 1,907 shares — an estimated $387K sold.

XTX Markets first reported a position in AMGN in Q1 2020 and held it in 1 quarter. The position peaked at $387K in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

XTX Markets reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
XTX Markets sold 1,907 Amgen shares in Q2 2020, an estimated $387K.
XTX Markets first reported a position in Amgen in Q1 2020 and held it in 1 quarter.
XTX Markets's Amgen position peaked at $387K in Q1 2020.
2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on XTX Markets's 13F filing for Q2 2020, filed 23 Jul 2020.